Lumida
/SRNE
⌘K
Sorrento Therapeutics Inc

Sorrento Therapeutics Inc

SRNE
$0.00USD+0.00%+0.00 today

MARKET CAP

220,512

P/E (TTM)

FWD P/E

DAY RANGE

$0 – $0

52W RANGE

$0
$0
STATEMENT·Income statement
USD · GAAP
METRICFY 2018FY 2019FY 2020FY 2021FY 2022TREND
Sales, Adj.$21.2M$31.4M$40.0M$52.9M$62.8M
YoY %-86.0%+48.3%+27.2%+32.3%+18.8%
P / Sales
EV / Sales
Gross Profit, Adj.$14.1M$19.2M$30.0M$39.9M$29.4M
YoY %-90.4%+35.8%+56.5%+32.7%-26.3%
Margin %66.7%61.1%75.1%75.4%46.8%
EV / Gross Profit
EBITDA, Adj.$-140.9M$-248.4M$-229.8M$-385.1M$-362.6M
YoY %-534.0%-76.3%+7.5%-67.6%+5.8%
Margin %-665.0%-790.3%-574.7%-728.0%-577.1%
EV / EBITDA
EBIT$-150.4M$-259.4M$-244.5M$-401.5M$-504.3M
YoY %-693.7%-72.4%+5.7%-64.2%-25.6%
Margin %-709.8%-825.3%-611.5%-758.8%-802.6%
EV / EBIT
Net Income$-203.5M$-292.1M$-298.5M$-428.3M$-572.8M
YoY %-2328.9%-43.5%-2.2%-43.5%-33.7%
Net Margin-960.4%-929.2%-746.4%-809.6%-911.6%
EPS (GAAP)-$1.92-$2.35-$1.30-$1.45-$1.37
YoY %-1576.9%-22.4%+44.7%-11.5%+5.5%